Business Description
BioXcel Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US09075P1057
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | -0.77 | |||||
Debt-to-Equity | -1.79 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -17.52 | |||||
Beneish M-Score | 2.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -14.5 | |||||
3-Year EPS without NRI Growth Rate | -16.6 | |||||
3-Year FCF Growth Rate | -20.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.91 | |||||
9-Day RSI | 44.16 | |||||
14-Day RSI | 45.09 | |||||
6-1 Month Momentum % | -4.67 | |||||
12-1 Month Momentum % | -86.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.65 | |||||
Quick Ratio | 2.57 | |||||
Cash Ratio | 2.39 | |||||
Days Inventory | 571.44 | |||||
Days Sales Outstanding | 93.52 | |||||
Days Payable | 3096.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7 | |||||
Shareholder Yield % | -76.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.62 | |||||
Operating Margin % | -12146.45 | |||||
Net Margin % | -12974.86 | |||||
FCF Margin % | -11232.32 | |||||
ROE % | -2323.67 | |||||
ROA % | -127.86 | |||||
ROIC % | -2730.34 | |||||
ROC (Joel Greenblatt) % | -9373.37 | |||||
ROCE % | -154.28 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 57.9 | |||||
EV-to-EBIT | -0.7 | |||||
EV-to-Forward-EBIT | -1.24 | |||||
EV-to-EBITDA | -0.7 | |||||
EV-to-Forward-EBITDA | -1.31 | |||||
EV-to-Revenue | 84.03 | |||||
EV-to-Forward-Revenue | 44.84 | |||||
EV-to-FCF | -0.75 | |||||
Earnings Yield (Greenblatt) % | -142.86 | |||||
FCF Yield % | -192.76 |